top of page

GSS

Genetic Signatures Ltd

Life Sciences Tools and Services

·

Healthcare

7

comments

1

fund manager

past 90 days

About Genetic Signatures Ltd

Genetic Signatures Ltd. is an Australian-headquartered research company specializing in the identification and commercialization of genetic signatures for diagnosing infectious diseases. Founded in 2001, the company develops and sells diagnostic products for gastrointestinal, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical diseases. Genetic Signatures serves global markets across the Asia Pacific, EMEA, and Americas regions. The firm focuses on diagnostic and research marketplace solutions, utilizing proprietary technology to detect pathogens and improve clinical outcomes.

Commentary Volume

7

Comments

1

Fund managers

0

Past 90 days

SOURCE

ACTION

COMMENT PREVIEW

FUND MANAGER

DATE

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Loading...

.

​Loading...

Loading...

Loading...

Loading...

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Report a problem

Loading...

.

Loading...

Loading...

Loading...

Loading...

14 Mar 2025

ic

Ipsum Capital

"Lorem ipsum dolor sit amet...

Q4 Letter

14 Mar 2025

ic

Dolor Investments

"Lorem ipsum dolor sit amet...

Q4 Letter

🔒 21 more comments from 10 sources

Unlock full access

§ Important Notice

The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Commentary

Sector

Healthcare

Market cap

$17M

Fund managers

1 manager

First covered

31 July 2023

Last updated

31 July 2025

Company Details

Related Themes

ic

Ipsum Capital

6 comments

ic

Amet Funds

4 comments

ic

Dolor

3 comments

Top Investors Covering MIN

§ Reminder

The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Frequently asked questions about Genetic Signatures Ltd (ASX:GSS)

Frequently asked questions

Who is investing in Genetic Signatures Ltd (ASX:GSS)?

Fund managers including Pengana Capital Group have invested in Genetic Signatures Ltd (ASX:GSS).

What is the short interest in Genetic Signatures Ltd (ASX:GSS)?

According to ASIC filings, there is negligible or no short interest in Genetic Signatures Ltd (ASX:GSS).

What does Genetic Signatures Ltd (ASX:GSS) do?

Genetic Signatures Ltd. is an Australian-headquartered research company specializing in the identification and commercialization of genetic signatures for diagnosing infectious diseases. Founded in 2001, the company develops and sells diagnostic products for gastrointestinal, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical diseases. Genetic Signatures serves global markets across the Asia Pacific, EMEA, and Americas regions. The firm focuses on diagnostic and research marketplace solutions, utilizing proprietary technology to detect pathogens and improve clinical outcomes.

bottom of page